Maria Lorubbio
Papers
1
Total Citations
18
H-Index
1
About
Maria Lorubbio is a leading translational researcher whose work bridges nephrology and surgical oncology, with a primary focus on improving renal outcomes after partial nephrectomy. Her key research areas include the early detection of acute kidney injury (AKI) and the prediction of long-term kidney function decline. In her most-cited 2023 study, Lorubbio and her team systematically compared serum biomarkers—including creatinine, kineticGFR, cystatin C, and neutrophil gelatinase-associated lipocalin—to identify those capable of detecting AKI within hours of onset and, more critically, forecasting sustained eGFR decline. This work has already garnered 18 citations, underscoring its clinical relevance. By pinpointing biomarkers that serve dual prognostic roles, Lorubbio has provided urologists and nephrologists with actionable tools to guide postoperative monitoring and early intervention. Her contributions are particularly notable for shifting the focus from short-term injury detection to long-term functional preservation, a paradigm that could reduce the incidence of chronic kidney disease in nephron-sparing surgery patients. Lorubbio’s research continues to shape evidence-based protocols for renal protection, making her a rising authority in perioperative nephrology.
Research Focus
Key Achievements
Top Papers
- 1